Dr. Xin Wang | Epilepsy and neurophysiological research | Best Researcher Award
Associate Professor at The First Affiliated Hospital of Wenzhou , China
Dr. Xinshi Wang, M.D., Ph.D. is a Chief Physician, Associate Professor, and Doctoral Supervisor at the Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University. He specializes in epilepsy and cognitive disorders, focusing on molecular mechanisms and therapeutic interventions. Dr. Wang earned his Ph.D. in Neurology from Chongqing Medical University and completed international training as a Visiting Scholar at Monash University & Royal Melbourne Hospital Epilepsy Center. He serves as a Committee Member of the China Anti-Epilepsy Association and Deputy Chair of the Zhejiang Neurology Association Youth Committee. ✨📚
Publication Profile
Academic Background
Dr. Xinshi Wang pursued his Ph.D. in Neurology (2013–2017) at Chongqing Medical University, specializing in epilepsy and cognitive disorders 🧠. He obtained his M.Sc. in Neurology (2005–2008) from Wenzhou Medical University, further deepening his expertise in neurological research 🏥. His journey in medicine began with a B.Sc. in Clinical Medicine (1998–2003) at Wenzhou Medical University, where he built a strong foundation in clinical practice and patient care 🏨. With a commitment to advancing neurology, Dr. Wang integrates academic excellence with clinical innovation, contributing significantly to the field of neuroscience. 📚🔬
Professional Background
Dr. Xinshi Wang specializes in clinical and translational research in epilepsy and cognitive disorders, focusing on molecular mechanisms and therapeutic interventions 🔬💊. His dedication to advancing neurology led him to a Visiting Scholar position (Oct 2018 – Oct 2019) at Monash University Central Clinical School & Royal Melbourne Hospital Epilepsy Center, Australia 🌍🏥. This prestigious training, funded by the China Scholarship Council, allowed him to collaborate with global experts, enhancing his expertise in epilepsy research and innovative treatment strategies. His work continues to bridge the gap between laboratory discoveries and clinical applications for neurological disorders. 📚⚕️
🧠 Research Focus
Dr. Xinshi Wang’s research focuses on epilepsy, cognitive disorders, and stroke-related complications, with an emphasis on molecular mechanisms and therapeutic interventions 🧬💊. His studies explore anti-epileptic treatments, oxidative stress, NMDAR deactivation, and biomarkers of cognitive decline 🧪🧠. He has contributed to radiomics-based prediction models, stroke-associated pneumonia, and post-stroke epilepsy 📊🏥. His work also examines amyloid-β and tau pathology in neurodegeneration, advancing precision medicine in neurology. Through clinical and translational research, Dr. Wang aims to improve diagnostic tools and therapeutic strategies for epileptic disorders and cerebrovascular diseases. 🚑📚
Publication Top Notes
1️⃣ An automatic deep-learning approach for the prediction of post-stroke epilepsy after an initial intracerebral hemorrhage based on non-contrast computed tomography imaging 🧠🤖
Year: 2025 | Quantitative Imaging in Medicine and Surgery
2️⃣ Development and internal validation of a prognostic model for predicting tonic-clonic seizures during pregnancy in women with epilepsy 🤰⚡
Year: 2024 | BMC Pregnancy and Childbirth
3️⃣ Development and validation of radiology-clinical statistical and machine learning model for stroke-associated pneumonia after first intracerebral haemorrhage 🏥📊
Year: 2024 | Cited by: 1 | BMC Pulmonary Medicine
4️⃣ NAD+-boosting agent nicotinamide mononucleotide potently improves mitochondria stress response in Alzheimer’s disease via ATF4-dependent mitochondrial UPR 🧬🧠
Year: 2024 | Cell Death and Disease
Conclusion
Dr. Xinshi Wang is an exceptional candidate for the Best Researcher Award due to his profound contributions to neurology, epilepsy, and cognitive disorders 🧠. With high-impact publications in prestigious journals like Phytomedicine and CNS Neurosci Ther, he has significantly advanced research in neurodegenerative diseases. His work is backed by competitive research funding from NSFC and Zhejiang Natural Science Foundation 💰. As a leader in neurology associations, an editorial board member, and a global collaborator through his Monash University scholarship, Dr. Wang exemplifies excellence in clinical and translational research, making him a top contender for this prestigious award